文献速递冠心病

英格兰和威尔士急性心肌梗死1年死亡率下降的驱动因素:15年全国队列研究

Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study.
PubMed 文献 · Heart · 2026-03-25

1年死亡率从22.8%降至14.2%,绝对降低8.6个百分点,约68.2%可由已测量因素解释,其中循证药物治疗贡献27.7%、PCI贡献17.6%。

要点

  • 1年全因死亡率15年间从22.8%降至14.2%,绝对降低8.6个百分点。
  • 循证药物治疗(他汀、β受体阻滞剂、ACEI)贡献27.7%的死亡率下降。
  • PCI使用增加贡献17.6%的死亡率下降,约三分之一下降仍未解释。

核心结论

  • 英格兰和威尔士AMI后1年生存率15年间大幅改善,主要归因于药物治疗和PCI的进步。
  • 约三分之一的死亡率下降仍未解释,需探究出院后护理和卫生系统等因素。

研究设计与样本

  • 采用分解分析量化临床、治疗和人口学因素对1年全因死亡率趋势的贡献。

主要发现

  • 1年全因死亡率从2005年的22.8%(95% CI 22.4%至23.2%)降至2019年的14.2%(95% CI 13.7%至14.7%),绝对降低8.6个百分点。
  • 约68.2%的死亡率下降可由已测量因素解释。
  • 循证药物治疗(他汀、β受体阻滞剂、ACEI)贡献27.7%(95% CI 26.0%至29.5%)的死亡率下降。
  • PCI使用增加贡献17.6%(95% CI 16.3%至19.0%)的死亡率下降。
  • STEMI和非STEMI人群均观察到死亡率改善,但老年人和女性在整个研究期间死亡率持续较高。

临床怎么用

  • 应持续推广循证药物治疗和PCI在AMI患者中的应用以维持死亡率下降趋势。
  • 对老年人和女性AMI患者需关注其持续较高的死亡风险并加强管理。
  • 需进一步研究出院后护理和卫生系统因素以解释剩余三分之一的死亡率下降。

局限性

  • 约三分之一死亡率下降未能由已测量因素解释,提示存在未测量混杂因素。
  • 研究为观察性注册数据分析,分解分析结果需谨慎解释因果关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: One-year mortality following acute myocardial infarction (AMI) has declined over time, yet the reasons for this improvement remain unclear. Understanding the drivers of these changes is essential for informing clinical strategies and health policy. METHODS: We analysed 852 914 adult patients admitted with AMI across England and Wales between 2005 and 2019 using national registry data. We examined changes in 1-year all-cause mortality and quantified the contribution of clinical, treatment and demographic factors to this trend using decomposition analysis. RESULTS: Between 2005 and 2019, 1-year all-cause mortality declined from 22.8% (95% CI 22.4% to 23.2%) to 14.2% (95% CI 13.7% to 14.7%), an absolute reduction of 8.6 percentage points. Approximately 68.2% of this decline was explained by measured factors. The greatest contributor was increased use of evidence-based pharmacological therapies-including statins, beta blockers and ACE inhibitors-accounting for 27.7% of the reduction (95% CI 26.0% to 29.5%). Increased use of percutaneous coronary intervention (PCI) contributed 17.6% (95% CI 16.3% to 19.0%). Mortality improvements were observed in both ST-elevation myocardial infarction (STEMI) and non-STEMI populations. However, older adults and women continued to experience higher mortality rates throughout the study period. CONCLUSION: One-year survival after AMI improved substantially over 15 years in England and Wales largely due to advances in pharmacotherapy and PCI. Nevertheless, about one-third of the mortality decline remains unexplained, underscoring the need to investigate other contributors such as postdischarge care and health system factors.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ayayo, Martin, Zghebi, et al. Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study. Heart. 2026. PMID: 40691042. doi:10.1136/heartjnl-2024-325474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。